Abstract
The growth-promoting actions of GH [growth hormone] are thought to be mediated by somatomedin(s) (Sms), but unilateral bone growth in hypophysectomized (HX) rats given local injections of human (h) GH were reported. Using slightly different methods, these results were confirmed with purified hGH; they were extended to show that 4 daily injections directly into the tibial epiphyseal plate of 1 or 5 .mu.g/day purified rat GH or recombinant DNA-derived hGH, but not of hPRL [prolactin] (6 .mu.g/day), caused significant cartilage growth compared to that of the vehicle-injected contralateral tibia in rats that were HX 14 days before the first injection. It is unlikely that the effects of GH are due to contaminating growth factors in the GH preparations, because the bacteria-derived preparation of hGH, which is unlikely to have such contaminants, was also active. Similar injections of 100 or 500 ng/day purified hSm-C caused unilateral tibial growth in rats HX 8 days, but not 14 days, before the first injection. Apparently, both GH and Sm-C have direct growth-promoting effects on cartilage in vivo, and they are compatible with the theory that GH may act by stimulating local Sm synthesis.